David M. Jackman

12.5k citations
87 papers · 7.6k · 4 hit papers · h-index 38

Impact in

  • Oncology top 0.2%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers
    • HER2/EGFR in Cancer Research
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Treatments and Mutations 59
    • Lung Cancer Diagnosis and Treatment 23
    • Brain Metastases and Treatment 5
    • Lung Cancer Research Studies 25
    • Colorectal Cancer Treatments and Studies 19
    • HER2/EGFR in Cancer Research 9

David M. Jackman

86 papers receiving 7.4k citations

David M. Jackman's Hit Papers

Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Study 2018 · 539 citations
5390+5+11Years since publication200400600

Peers

David M. Jackman
Comparison fields: 5 of 129
  • Oncology 4.9k
  • Pulmonary and Respiratory Medicine 5.6k
  • Cancer Research 1.7k
  • Molecular Biology 2.0k
  • Pathology and Forensic Medicine 433
Replace Daniel de Castro with:
Daniel de Castro Spain
Rafał Dziadziuszko Poland
Haiyi Jiang Japan
Rafael Rosell Spain
Rogério Lilenbaum United States
Renato Martins United States
M. Pérol France
Sanja Đačić United States
Junming Zhu China
Chun‐Ming Tsai Taiwan
David M. Jackman relative to Daniel de Castro Spain Daniel de Castro's profile →
Citations per field
00.5×2.9×
Daniel de Castro · 1×
Citations per year

Countries citing papers authored by David M. Jackman

Since Specialization
Citations

This map shows the geographic impact of David M. Jackman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Jackman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Jackman more than expected).

Fields of papers citing papers by David M. Jackman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Jackman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Jackman. The network helps show where David M. Jackman may publish in the future.

Co-authors

The 25 scholars most cited alongside David M. Jackman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David M. Jackman Line = papers co-authored together David M. Jackman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer
Hit paper breakdown →
2009644
2
Noninvasive Detection of Response and Resistance in EGFR -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
Hit paper breakdown →
2014590
3
Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Study
Hit paper breakdown →
2018539
4
MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
Hit paper breakdown →
2016493
5 2006491
6 2005405
7 2009312
8 2013261
9 2007254
10 2015252
11 2015211
12 2006205
13 2010176
14 2015172
15 2010159
16 2012144
17 2008136
18 2014110
19 2013102
20 200896

About David M. Jackman

David M. Jackman is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 87 papers that have together received 7.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (59 papers), Lung Cancer Research Studies (25 papers), Lung Cancer Diagnosis and Treatment (23 papers), Colorectal Cancer Treatments and Studies (19 papers), Cancer Genomics and Diagnostics (10 papers), HER2/EGFR in Cancer Research (9 papers), Economic and Financial Impacts of Cancer (6 papers) and Brain Metastases and Treatment (5 papers). The work is most often cited by research in Oncology (4.9k citations), Pulmonary and Respiratory Medicine (5.6k citations), Cancer Research (1.7k citations), Molecular Biology (2.0k citations) and Pathology and Forensic Medicine (433 citations). David M. Jackman has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Bruce E. Johnson, Pasi A. Jänne, Geoffrey R. Oxnard, Beow Y. Yeap, Suzanne E. Dahlberg, Lecia V. Sequist, Neal I. Lindeman, Michael S. Rabin, Mohit Butaney and Thomas J. Lynch. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Journal of Thoracic Oncology, Lung Cancer and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact